What the Mount Raymond acquisition means for SLAM Exploration Ltd.’s Goodwin project scale (TSXV: SXL)
Read More 4 minute read Pharma Industry News Novo Nordisk stock rises on Wegovy STEER data: Can semaglutide cement its lead over Eli Lilly? Novo Nordisk shares gained after STEER study showed Wegovy cut heart risks by 57% over tirzepatide. Find out why semaglutide may lead the GLP-1 race. byPallavi MadhirajuSeptember 1, 2025